Actelion Hub

In her interview with Outsourcing Pharma, our Chief Commercial Officer, Henny Zijlstra, highlighted our customer-centric approach and ability to optimise and invest in every site we take on. Find the complete article below. German CDMO Actelion Pharmaceuticals Deutschland GmbH has its eye […]

Plettenberg / Munich / Halden, November 15, 2023 – Prange Group and its affiliate Actelion Pharmaceuticals Deutschland GmbH have announced the signing of definitive agreements with Fresenius Kabi for the acquisition of the leading sterile pharmaceutical production site in Halden, Norway. As […]

Dear Valued Partners and Industry Enthusiasts, We are thrilled to announce that the Actelion Pharmaceuticals Deutschland GmbH team will be participating in one of the pharmaceutical industry’s most prestigious events – CPHI Barcelona 2023, taking place in beautiful Barcelona from October 24th […]

Munich, Germany / Tokyo, Japan, June 15, 2023 — Actelion Pharmaceuticals Deutschland GmbH GmbH, a global leader in pharmaceutical manufacturing, announced today that it has completed the divestiture of its subsidiary Toride Pharma K.K., and its associated entity, Toride Asset Trading Co. […]

Actelion on a growth path: Three locations in Europe and five globally Acquisition strengthens actelion’ end-to-end integrated pharmaceutical product development service offering Agreement on further product development activities for Clinigen Munich / London / Athens, April 3, 2023 – Munich-based […]

Actelion Pharmaceuticals Deutschland GmbH acquires Clinigen’s development unit, Lamda Laboratories Acquisition strengthens Actelion end-to-end integrated service offering within the pharmaceutical product development segment Agreement includes further product development activities for Clinigen Limited Lamda spurs further growth for Actelion as its 3rd site […]